Angitrim

Trimetazidine Dihydrochloride, marketed as Angitrim, is a medication used to improve heart function and manage angina symptoms. It works by enhancing cellular metabolism and reducing ischemic damage.

Trimetazidine Dihydrochloride is primarily used to treat angina pectoris, a condition characterized by chest pain due to reduced blood flow to the heart. It is also used to manage symptoms of vertigo and tinnitus associated with inner ear disorders. The medication helps by improving the efficiency of energy production in cells, particularly in the heart and inner ear.

Common effects of Trimetazidine Dihydrochloride may include gastrointestinal discomfort, nausea, and dizziness. Some users might experience headaches or mild allergic reactions. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Trimetazidine Dihydrochloride should be used with caution in individuals with liver or kidney impairment. It is important to follow the prescribed dosage and administration instructions. Pregnant or breastfeeding women should consult a healthcare provider before using this medication.

Trimetazidine Dihydrochloride may interact with other medications, including those metabolized by the liver's cytochrome P450 system. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.